HCPCS code J9171: Docetaxel injection, per 1 mg2026 Medicare rate & RVUs in Illinois
Reports docetaxel, an intravenous chemotherapy drug, by the milligram administered during treatment of cancers such as breast, lung, and prostate cancer.
CMS doesn’t publish an office rate for J9171 in Illinois.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
Your location
On this page 9 sections
What J9171 covers
Docetaxel is an antineoplastic taxane given by intravenous infusion. Oncology practices and hospital-based cancer services report it when administering docetaxel as chemotherapy, including in treatment regimens for breast, non-small-cell lung, prostate, gastric, and head and neck cancers. This code identifies the drug quantity, not the infusion service itself.
Each unit represents 1 mg of docetaxel; for example, 75 mg corresponds to 75 units. CMS assigns physician fee schedule status E, meaning the drug is excluded from the physician fee schedule. When Medicare covers it, payment is generally made under the Part B drug method using CMS quarterly Average Sales Price drug pricing files. Special Medicare coverage instructions apply. Report the applicable chemotherapy administration service separately when supported by the encounter.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Where J9171 pays more and less in Illinois
The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.
| Payment locality | Office | Facility |
|---|---|---|
| Chicago, IL | Unavailable | Unavailable |
| East St. Louis, IL | Unavailable | Unavailable |
| Rest of Illinois | Unavailable | Unavailable |
| Suburban Chicago, IL | Unavailable | Unavailable |
How the J9171 rate is calculated
Each of J9171’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · J9171
RVUs × geographic indexes × conversion factor
Work0.00
0.00 RVUs× 1.000 GPCI
Practice expense0.00
0.00 RVUs× 1.000 GPCI
Malpractice0.00
0.00 RVUs× 1.000 GPCI
Adjusted RVUs
0.0000
Conversion factor
$33.4009
Medicare rate
$0.00
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for J9171
J9171 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.
Place of service · J9171
Which rate does Medicare pay?
The POS code on the claim line (CMS-1500 box 24B).
POS 11 · non-facility rate · national
—
J9171 isn’t priced in this setting.
J9171 compared with similar codes
Compare codes · National
J9171 vs J9172 vs J9174: Medicare rates
How to choose
- J9172Docetaxel injectionDocivyx, per 1 mg
- J9172 identifies docetaxel (Docivyx) by product. Use it when that is the product administered rather than reporting the generic docetaxel code.
- J9174Docetaxel injectionBeizray, per 1 mg
- J9174 identifies docetaxel (Beizray) by product. Match the code to the product administered; J9171 identifies docetaxel without that product-specific distinction.
J9171 billing questions
How many units should be reported?
Report one unit for each 1 mg of docetaxel administered. A 75 mg dose corresponds to 75 units.
Does this code include the infusion service?
No. J9171 reports the docetaxel drug quantity; the chemotherapy administration service is reported separately when supported.
How does J9171 differ from J9172 and J9174?
J9171 identifies docetaxel by its generic drug description. J9172 and J9174 identify specific docetaxel products, so select the code that matches the product administered.
Does Medicare pay J9171 under the physician fee schedule?
No. CMS assigns status E, excluding it from the physician fee schedule. When covered, it is generally paid through the Part B drug method using quarterly ASP drug pricing files.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Fee sheets · Coming soon
Put J9171 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist